After a FVIII gene transfer by injecting E-F8-LVs into tibias in hemophilia A mice, up to 20% of plasma FVIII activity was detected initially but dropped to undetectable levels within 2–3 months due to the development of FVIII inhibitors. The gene discussed is F8; the disease is hemophilia A.